Neurocrine Biosciences Inc (NAS:NBIX)
$ 140.32 -1.68 (-1.18%) Market Cap: 14.12 Bil Enterprise Value: 13.56 Bil PE Ratio: 38.66 PB Ratio: 5.92 GF Score: 89/100

Q2 2019 Neurocrine Biosciences Inc Earnings Call Transcript

Jul 29, 2019 / 08:30PM GMT
Release Date Price: $86.97 (-0.58%)
Operator

Hello, and thank you for joining the Neurocrine Biosciences Reports Second Quarter 2019 Results Call. (Operator Instructions) Please note, this call may be recorded.

(Operator Instructions)

It is now my pleasure to turn today's conference over to Kevin Gorman, CEO. Please go ahead.

Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director

Thank you very much, and thank you, everyone, for taking the time to join us on our Q2 earnings call. On this call, I'm joined by Kyle Gano, our Chief Strategy and Business Development Officer; Eiry Roberts, our Chief Medical Officer; Matt Abernethy, Chief Financial Officer; and Eric Benevich, Chief Commercial Officer.

Now during this call, we will all be making forward-looking statements. So Jane, could you please read our safe harbor statement.

Jane Sorensen
Neurocrine Biosciences, Inc. - Head of IR

Yes, good afternoon. Certain statements made in the course of this conference call that are not historical statements may be forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot